HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

UK Health Food Chain Reinstates CBD Products After FSA-Related Review

Executive Summary

The UK's largest health food chain Holland & Barrett has reinstated over 30 CBD products after initially removing them from shelves in response to the FSA's recommendation that consumers should only take 10mg CBD a day. 

You may also be interested in...



FSA Should Review 10mg CBD Daily Guideline Based On Latest Toxicology Data

The UK Food Standards Agency should review its recently published guidance recommending an acceptable daily intake (ADI) of 10mg cannabidiol for consumers, says food law expert Mark Tallon. Data in the public domain, such as that published by Tallon and colleague Robert Child shows that short-term consumption of CBD isolate is safe for adults at circa 100mg per day if applying the FSA’s assessment approach, he explains.

10mg CBD Per Day – UK Food Regulator Sets ‘Provisional’ Acceptable Daily Limit

The UK Food Standards Agency has issued new advice aimed at consumers warning them not to take more than 10mg CBD per day, an acceptable daily intake level significantly lower than the agency's previous ADI of 70mg per day. However, CBD brand owners should not reformulate their products, Canna Consultants warns, as this would be a breach of FSA's conditions for remaining on the market. 

Over The Counter 20 Feb 2024: AESGP’s 60th Birthday Celebrations In 2024 Including Annual Meeting, With Jurate Švarcaite

The Association of the European Self-Care Industry celebrates its 60th birthday this year. In this episode, we catch up with AESGP director general, Jurate Švarcaite, to find out how the association will mark the occasion, including at this year’s Annual Meeting in Brussels in June. AESGP Annual Meetings are an excellent way to find out what the key issues and trends are impacting the European consumer health industry, and this one will be no different. We talk through some of the key themes of this year’s conference. Sustainability continues to be a mega-trend, closely followed by digitalization and artificial intelligence. With its wide-ranging footprint across OTC medicines, food supplements and self-care medical devices sectors, the consumer health industry is facing an avalanche of regulations, and the AESGP continues to be an effective advocate for its stakeholders, alongside adjacent industry partners. 

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS154146

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel